Literature DB >> 17374000

Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.

G Seifert, C Tautz, K Seeger, G Henze, A Laengler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17374000     DOI： 10.1111/j.1468-3083.2006.01958.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  5 in total

Review 1.  Herbal therapy use by cancer patients: a literature review on case reports.

Authors:  Oluwadamilola Olaku; Jeffrey D White
Journal:  Eur J Cancer       Date:  2010-12-23       Impact factor: 9.162

Review 2.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

3.  Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.

Authors:  Georg Seifert; Sarah B Blakeslee; Gabriele Calaminus; Farid I Kandil; Andrea Barth; Toralf Bernig; Carl Friedrich Classen; Selim Corbacioglu; Jürgen Föll; Sven Gottschling; Bernd Gruhn; Claudia Vom Hoff-Heise; Holger N Lode; David Martin; Michaela Nathrath; Felix Neunhoeffer; Arnulf Pekrun; Beate Wulff; Tycho Zuzak; Günter Henze; Alfred Längler
Journal:  BMC Cancer       Date:  2022-06-13       Impact factor: 4.638

4.  Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors.

Authors:  Gunver S Kienle; Milena Mussler; Dieter Fuchs; Helmut Kiene
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-24       Impact factor: 2.629

5.  Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.

Authors:  Maurice Orange; Aija Lace; Maria P Fonseca; Broder H von Laue; Stefan Geider; Gunver S Kienle
Journal:  Glob Adv Health Med       Date:  2012-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.